Valute / BMRN
BMRN: BioMarin Pharmaceutical Inc
55.91
USD
1.41
(2.59%)
Il tasso di cambio BMRN ha avuto una variazione del 2.59% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 54.20 e ad un massimo di 55.94.
Segui le dinamiche di BioMarin Pharmaceutical Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN News
- Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation
- Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
- PTC Therapeutics To Challenge BioMarin's Metabolic Disorder Treatment - BioMarin Pharmaceutical (NASDAQ:BMRN)
- This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Bullish (NYSE:BLSH), BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin’s PKU drug shows nearly 50% blood Phe reduction in teens
- BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Cantor Global Healthcare Conference 2025
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
- BioMarin stock rating reiterated at Outperform by Oppenheimer on Voxzogo strength
- BioMarin stock price target raised to $95 by Bernstein following Inozyme acquisition
- BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
- Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
- BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
- 3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts - TipRanks.com
- BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call Transcript
- BioMarin (BMRN) Q2 Revenue Jumps 16%
- BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- BioMarin (BMRN) Q2 2025 Earnings Call Transcript
- Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises
- BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
- After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
Intervallo Giornaliero
54.20
55.94
Intervallo Annuale
52.94
73.51
- Chiusura Precedente
- 54.50
- Apertura
- 54.46
- Bid
- 55.91
- Ask
- 56.21
- Minimo
- 54.20
- Massimo
- 55.94
- Volume
- 4.773 K
- Variazione giornaliera
- 2.59%
- Variazione Mensile
- -4.26%
- Variazione Semestrale
- -20.36%
- Variazione Annuale
- -20.50%
11 settembre, giovedì
08:00
ALL
- Agire
- Fcst
- Prev
11:00
ALL
- Agire
- Fcst
- Prev
12:30
USD
- Agire
- Fcst
- 0.2%
- Prev
- 0.2%
12:30
USD
- Agire
- Fcst
- 0.3%
- Prev
- 0.3%
12:30
USD
- Agire
- Fcst
- 2.9%
- Prev
- 2.7%
12:30
USD
- Agire
- Fcst
- 3.3%
- Prev
- 3.1%
12:30
USD
- Agire
- Fcst
- Prev
- 0.2%
12:30
USD
- Agire
- Fcst
- 322.956
- Prev
- 322.132
12:30
USD
- Agire
- 263 K
- Fcst
- 235 K
- Prev
- 236 K
12:30
USD
- Agire
- 1.939 M
- Fcst
- 1.923 M
- Prev
- 1.939 M
17:00
USD
- Agire
- 4.651%
- Fcst
- Prev
- 4.813%
18:00
USD
- Agire
- $-344.8 B
- Fcst
- $-283.5 B
- Prev
- $-291.1 B